Phthalate producers consider options under REACH
DEHP is on the EU candidate list but there is an exemption for medical uses
16.08.2010 | CW Briefing
| Next |
According to REACH Article 60.2 on the granting of authorisations, the
European Commission will not consider risks to human health arising from
the use of a substance in medical devices regulated by any of three
existing EU Directives on medical devices, and this provision - as
Arkema general manager David Royer points out - will apply to the use of
DEHP in blood bags. “We are, of course, very committed and confident
to go on selling in this application.” Arkema is not working yet on
the development of alternatives for low molecular weight phthalates such
as DEHP.
To read an article “Phthalate producers consider options under REACH” visit http://chemicalwatch.com/3989?q=phthalates
Related News
![]() |
Astonishing Findings of a New Research on Chemical Pesticides in Armenia by WECF Partner AWHHE |
![]() |
Could Playing and Swimming in the Pool Be More Than Just Fun and a Good Exercise for Pregnant Women and Young Children? |
![]() |
WECF pushes for stronger Toys Safety Directive |
Toys in a Black List of Products, Containing Carcinogenic Chemicals |
![]() |
WECF and Eco-Accord Report of the 7th ‘Environment for Europe’ Ministerial Conference, 2011, Astana |






























"We improve the direct living conditions of some hundred thousand people. Through our advocacy work we reach out to millions".


